Groowe Groowe / Newsroom / CADL
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

CADL News

Candel Therapeutics, Inc. Common Stock

Candel Therapeutics to Present at the SITC 2025 Annual Meeting

globenewswire.com
CADL

Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025

globenewswire.com
CADL